BORTEZOMIB ACCORD 2,5 mg/ml, solution injectable — 1 flacon(s) en verre de 1,4 ml
Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France
-
CIP13
3400930233405 -
CIP7
3023340 -
CIS
61684207 -
Registration number
EU/1/15/1019
What the source publishes
- Holder
- ACCORD HEALTHCARE (ESPAGNE)
- Active ingredients
- ESTER BORONIQUE DE MANNITOL, BORTÉZOMIB
- Form
- solution injectable
- Package
- 1 flacon(s) en verre de 1,4 ml
- Routes
- intraveineuse, sous-cutanée
- Administrative status
- authorised
- Supply regime
- médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE ; prescription réservée aux spécialistes et services HEMATOLOGIE ; prescription hospitalière ; liste I ; prescription réservée aux médecins compétents en CANCEROLOGIE
- Marketing status
- Déclaration de commercialisation
- Authorised on
- 2021-07-23
- Prescription
- Prescription or restricted
Names this record is found by
- BORTEZOMIB ACCORD 2,5 mg/ml, solution injectable — 1 flacon(s) en verre de 1,4 ml
- BORTEZOMIB ACCORD 2,5 mg/ml, solution injectable
- ESTER BORONIQUE DE MANNITOL
- BORTÉZOMIB
Complete source data
{
"cis": "61684207",
"cip7": "3023340",
"form": "solution injectable",
"name": "BORTEZOMIB ACCORD 2,5 mg/ml, solution injectable — 1 flacon(s) en verre de 1,4 ml",
"cip13": "3400930233405",
"holder": "ACCORD HEALTHCARE (ESPAGNE)",
"routes": [
"intraveineuse",
"sous-cutanée"
],
"holders": [
"ACCORD HEALTHCARE (ESPAGNE)"
],
"currency": "EUR",
"marketed": true,
"bdmStatus": null,
"useDomain": "unknown",
"publicPrice": null,
"authorisedOn": "2021-07-23",
"compositions": [
{
"name": "ESTER BORONIQUE DE MANNITOL",
"nature": "SA",
"strength": null,
"linkageNumber": "1",
"substanceCode": "60273",
"dosageReference": null,
"pharmaceuticalElement": "solution"
},
{
"name": "BORTÉZOMIB",
"nature": "FT",
"strength": "2,5 mg",
"linkageNumber": "1",
"substanceCode": "98525",
"dosageReference": "1 mL de solution",
"pharmaceuticalElement": "solution"
}
],
"sourceStatus": "Présentation active",
"supplyRegime": "médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE ; prescription réservée aux spécialistes et services HEMATOLOGIE ; prescription hospitalière ; liste I ; prescription réservée aux médecins compétents en CANCEROLOGIE",
"dispensingFee": null,
"medicinePrice": null,
"regionalRules": "not-collected",
"targetSpecies": [],
"specialityName": "BORTEZOMIB ACCORD 2,5 mg/ml, solution injectable",
"marketingStatus": "Déclaration de commercialisation",
"publicationDates": {
"CIS_bdpm": "2026-01-08",
"CIS_CIP_bdpm": "2026-11-19",
"CIS_CPD_bdpm": "2026-01-08",
"CIS_COMPO_bdpm": "2026-01-08"
},
"specialityListed": true,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "fr.ansm.bdpm"
},
"collectiveApproval": "oui",
"packageDescription": "1 flacon(s) en verre de 1,4 ml",
"patientEligibility": "not-assessed",
"reimbursementRates": [],
"marketingDeclaredOn": "2022-03-21",
"targetSpeciesStatus": "not-reported",
"additionalMonitoring": false,
"administrativeStatus": "authorised",
"prescriptionCategory": "prescription-or-restricted",
"activeIngredientNames": [
"ESTER BORONIQUE DE MANNITOL",
"BORTÉZOMIB"
],
"authorisationProcedure": "Procédure centralisée",
"prescriptionConditions": [
"médicament nécessitant une surveillance particulière pendant le traitement",
"prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE",
"prescription réservée aux spécialistes et services HEMATOLOGIE",
"prescription hospitalière",
"liste I",
"prescription réservée aux médecins compétents en CANCEROLOGIE"
],
"reimbursementIndications": null,
"authorisationSourceStatus": "Autorisation active",
"europeanAuthorisationNumber": "EU/1/15/1019",
"presentationAdministrativeStatus": "authorised"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=fr" \
--data-urlencode "sourceId=fr.ansm.bdpm" \
--data-urlencode "id=fr:ansm:packages:3400930233405"